期刊文献+

氢吗啡酮联合芬太尼用于颌面部手术后镇痛效果观察 被引量:4

ANALGESIC EFFECTS OF HYDROMORPHONE COMBINED FENTANYL ON POSTOPERATIVE ANALGESIA OF MAXILLOFACIAL SURGERY
下载PDF
导出
摘要 目的:评价氢吗啡酮联合芬太尼用于颌面部手术患者术后自控静脉镇痛的效果。方法:40例择期行颌面部手术的患者随机分为氢吗啡酮+芬太尼(H)组和芬太尼(F)组,每组20例。两组术后均采用患者静脉自控镇痛的方式,F组芬太尼1.0mg;H组氢吗啡酮1.6mg+芬太尼0.5mg,记录术后2h、4h、8h、12h、24h的疼痛评分(VAS评分)和Ramsay镇静评分(RSS评分),观察恶心、呕吐、眩晕等不良反应的发生情况。结果:两组患者术后各时间点VAS评分、RSS评分比较差异无统计学意义(P>0.05)。镇痛治疗期间H组患者恶心呕吐、眩晕的发生率明显低于F组(P<0.05)。结论:氢吗啡酮联合芬太尼与单用芬太尼用于颌面部手术术后镇痛的效果相当,但不良反应发生率明显较低,更适用于颌面部手术术后镇痛。 Objective:To evaluate the effects of hydromorphone combined fentanyl on postoperative patient control intravenous analgesia(PCIA) of maxillofacial surgery patients. Methods:40 cases selective maxillofacial surgery patients were randomly divided into hydromorphone combined fentanyl(H) group and fentanyl(F) group(n=20). These 2 groups all used PCIA: patients in H group used hydromorphone(1.6mg) combined fentanyl(0.5mg); patients in F group only used fentanyl(1.0mg). The VAS score and RSS score of patients in 2 groups were recorded 2h, 4h, 8h, 12 h, 24 h after operation respectively; as well as adverse effects. Results:There had no statistical signifi cance about VAS score and RSS score of 2 groups at each time point after operation(P〉 0.05). The incidence rate of adverse effects(nausea, vomiting and dizziness) of H group were obviously lower than that of F group(P〈0.05). Conclusions:The analgesic effects of hydromorphone combined fentanyl is same as fentanyl after maxillofacial surgery, but adverse effects are fairly lower. So hydromorphone combined fentanyl is more comfortable and safer for maxillofacial surgery.
出处 《承德医学院学报》 2015年第1期23-24,共2页 Journal of Chengde Medical University
关键词 氢吗啡酮 芬太尼 颌面部手术 Hydromorphone Fentanyl Maxillofacial surgery
  • 相关文献

参考文献8

  • 1Parker RK, Holtmann B,White PF.Patient-controlled epidural analgesia: interactions between nalbuphine and Analg, 1997,84(4):757-763.
  • 2Rapp SE, Egan KJ, Ross BK, et al. A multidimensional comparison of morphine and hydromorphone patient-conlrolled analgesia[J].Anesth Analg,1996,82(5):1043-1048.
  • 3Lussier D,Richarz U,Finco G. Use of hydromorphone, with particular reference to the OROS formulation, in the elderly[J]. Drugs Aging2010.27(4):327-335.
  • 4Liukas A,Kuusniemi K,Aantaa R, et al.Plasma concentrations of oral oxycodone are greatly increased in the elderly[J].Clin Phanna:l Ther,2008,84(4):462-467.
  • 5Coda B,Tanaka A,Jaeobson RC,et al.Hydromorphone analgesia after intravenous bolus administration[J] .Pain, 1997,71 ( 1 ):41-48.
  • 6Chang AK, Bijur PE,Lupow JB,et al.Randomized clinical trial of the 2mg hydromorphone bolus protocol versus the 1+1 hydromorphone titration protocol in trealrnent of acute, severe pain in the first hour of emergency department presentation[J]. Ann Emer: Meck2013.62(4): 304-310.
  • 7董稳,刘瑞昌,刘克英,关明,杨旭东.氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J].北京大学学报(医学版),2009,41(1):109-111. 被引量:12
  • 8Kim SY, Kim EM,Nam KH,et al.Postoperative intravenous patient-controlled analgesia in thyroid surgery: comparison of fentanyl and ondansetron regimens with and without the nonsteroidal anti-inflammatory drug ketorolac[J]. Thyroid,2008,18(12): 1285-1290.

二级参考文献4

共引文献11

同被引文献19

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部